StemCells, Inc. Announces Completion of the First of Two Cohorts in its Dry Age-Related Macular Degeneration Trial
February 12, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has completed enrollment of the first of two planned patient cohorts in the Company's clinical...
StemCells, Inc. Announces Presentation at Two Upcoming Investor Conferences
January 30, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Jan. 30, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn will present at the following conferences:
16th Annual BIO CEO & Investor...
StemCells, Inc. Technology is Featured in Canadian TV Broadcast
January 13, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Jan. 13, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its technology was featured January 10 in a television segment which aired at 10 PM on CTV News...
StemCells, Inc. Expands Phase I/II Spinal Cord Injury Trial to North America
January 10, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Jan. 10, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that a team at the University of Calgary successfully transplanted its first subject in the Company's...
StemCells, Inc. to Discuss Plans for Advancing Clinical Studies in Spinal Cord Injury and Age Related Macular Regeneration
January 07, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Jan. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Eliseo Salinas, M.D., Executive Vice President and Head of Research and Development, will provide an...
StemCells, Inc. Posts Letter to Shareholders
January 06, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Jan. 6, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, posted...
StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer
November 14, 2013 09:00 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 14, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, today...
StemCells, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
November 05, 2013 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 5, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss Third Quarter 2013 Financial Results and Business Update
October 31, 2013 09:00 ET
|
StemCells, Inc.
NEWARK, Calif., Oct. 31, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio
October 29, 2013 09:00 ET
|
StemCells, Inc.
NEWARK, Calif., Oct. 29, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents to which it had previously held an...